RXST 241220 62.50P (RXST241220P62500) Stock Options, News & Quotes

US OptionsDetailed Quotes

RXST241220P62500

Watchlist

17.64
0.000.00%

15min DelayTrading Jul 22 10:32 ET

0.00High0.00Low

Intraday

5D
Daily

News

Insider Sale: Director at $RXST (RXST) Sells 3,782 Shares
Quiver QuantitativeNov 26 19:31 ET
3 'Buy' Stocks and 2 'Hold' Stocks According to Oppenheimer
Seeking AlphaNov 22 10:58 ET
RxSight (RXST) Upgraded to Buy: Here's What You Should Know
Yahoo FinanceNov 20 12:00 ET
Alkermes, DaVita, Jabil, Ralph Lauren, Among Potential M&A Candidates - BofA
Seeking AlphaNov 17 09:18 ET
Jesse Corley Bought 4.4% More Shares In RxSight
Simply Wall StNov 17 07:52 ET
RxSight Insider Bought Shares Worth $1,014,570, According to a Recent SEC Filing
MT NewswiresNov 15 03:35 ET

Comments

Meltyy

May 16 01:19

🔔 RA Capital Q1 ‘24* Holdings Released... 🐳

» Holdings: 75
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S (ASND.US)$
$Vaxcyte (PCVX.US)$
$Legend Biotech (LEGN.US)$
$Janux Therapeutics (JANX.US)$
$Aerovate (AVTE.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Evolent Health (EVH.US)$
$NewAmsterdam Pharma (NAMS.US)$
$RxSight (RXST.US)$
$TYRA BIOSCIENCES, INC. (TYRA.US)$
$Edgewise Therapeutics (EWTX.US)$
$4D Molecular Therapeutics (FDMT.US)$
$Biogen (BIIB.US)$
$PepGen (PEPG.US)$
...

Moomoo AI

Feb 5 04:22

The recent insider sale of RxSight shares and the absence of insider purchases over the last year raise concerns about the company's outlook. Despite significant insider ownership, the lack of insider buying does not inspire confidence in the company's prospects.

Trade Alert: Independent Director Of RxSight William Link Has Sold Stock

Bigmoney Dreamer

Jan 8 14:23

$RxSight (RXST.US)$ oww back in action now sold too early

Bigmoney Dreamer

Dec 15, 2023 18:26

$RxSight (RXST.US)$ 213 % runs looks good here priming to jump 🔥

Bigmoney Dreamer

Dec 14, 2023 12:38

$RxSight (RXST.US)$ bought few lets fo !